Suggestions
Dave English
Chief Executive Officer ◆ Start Up/Early Stage ◆ Led Global Teams of over 300 Professionals ◆ $500MM P&L Responsibility◆ $150 million Revenue Growth ◆ Raised $100MM in Private Equity Financing ◆ Turn Around Specialist
Dave English is a prominent figure in the healthcare industry, currently serving as the Managing Director at Ascendant Biomedical.12 His professional background includes extensive experience in healthcare industry operations and sales leadership.1
Professional Achievements
At Ascendant Biomedical, Dave English has made significant contributions:
- Secured $100 Million in Equity Financing: This substantial financial achievement demonstrates his ability to attract major investments for the company.
- Leadership: He has led over 3,000 employees of clients, showcasing his strong management and leadership skills in the healthcare sector.
Role at Ascendant Biomedical
As the Managing Director, Dave English plays a crucial role in the company's operations:
- Automation in Healthcare: He is spearheading efforts to automate healthcare processes through AI implementation.2
- Comprehensive Approach: His work involves various aspects of healthcare management, including lead generation, relationship management, patient diagnosis, and prescribed treatments.2
Professional Background
Dave English's career history includes:
- Military Experience: He has educational background from the United States Naval Academy, which likely contributes to his leadership skills.1
- Healthcare Expertise: His experience in the healthcare industry spans operations and sales leadership, making him well-suited for his current role.1
Online Presence
Dave English maintains a professional online presence:
- LinkedIn: His LinkedIn profile can be found under the username davidmenglish1.1
- Location: He is based in Phoenix, AZ, United States.3
Dave English's role at Ascendant Biomedical and his significant achievements in equity financing and leadership demonstrate his importance in the healthcare technology sector, particularly in advancing AI-driven healthcare solutions.
Highlights
May 19 · nytimes.com
Death of a Biohacker - The New York Times